 |
市場調査レポート
ペプチド治療薬の世界市場：2019年～2023年Global Peptide Therapeutics Market 2019-2023 |
||||||
| 発行 | TechNavio (Infiniti Research Ltd.) | 商品コード | 317311 | ||||
| 出版日 | ページ情報 | 英文 118 Pages  |
|||||
| 価格 |
|
||||||
| ペプチド治療薬の世界市場：2019年～2023年 Global Peptide Therapeutics Market 2019-2023 | ||
| 出版日: 2018年12月24日 | ページ情報: 英文 118 Pages |
|
世界のペプチド治療薬市場は、癌、糖尿病、肥満、心血管疾患などの慢性疾患の増加などにより成長しています。ペプチドはこれらの疾患の治療に高い効果を示すことが知られています。同市場は、2023年まで9%のCAGR (複合年間成長率) で拡大すると予測されています。
当レポートでは、世界のペプチド治療薬市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入するベンダーのプロファイルについてまとめています。
One of the major drivers of the global peptide therapeutics market is the growing cases of chronic diseases such as cancer, diabetes, obesity, and various cardiovascular diseases. Peptides are known to have high efficacy in the treatment of these diseases. Hence the use of peptides has increased significantly in recent years with the growing prevalence of chronic conditions. The high prevalence of chronic conditions leads to significant demand for curative drugs such as peptides thereby driving market growth. Moreover, the significant need for the treatment of these diseases has led various pharmaceutical companies to develop therapies, including peptide-based drugs. Technavio's analysts have predicted that the peptide therapeutics market will register a CAGR of almost 9% by 2023.
Currently the treatment of various diseases with peptides is predominantly done by administering drugs through the parenteral route. The parenteral RoA is considered to be one of the most undesirable routes for patients due to the invasive nature of the drug administration. Hence. vendors are focusing on developing better drug delivery systems. The increasing need for novel drug delivery systems has led to the development of self-injectable pens by various vendors.
One of the major challenges faced by the global peptide therapeutics market is the stringent policies set by regulatory bodies globally. The policies set for the approval of biologic drugs by regulatory bodies are more stringent than for small molecules, which makes it difficult for pharmaceutical companies to launch these drugs in the market. The late launch of drugs or FDA refusal of a drug can hinder the growth of the market during the forecast period.
For the detailed list of factors that will drive and challenge the growth of the peptide therapeutics market during the 2019-2023, view our report.
The market appears to be fragmented and with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.
